More on AUTL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (5/8/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Autolus Therapeutics (NQ:AUTL)
Delayed: 1.51 +0.03 (2.03%)
Prev. Close $1.48  
Open$1.51 
52 Wk High$ 
52 Wk Low$ 
Day High$1.55 
Day Low$1.49 
P/E N/A  
EPS$ 
Volume1,831,170 

Friends, Peers and Foes (?): A, AVBP, IPH, IPHA, 0A3M (more...)

Feb 24, 2026 07:00 AM Autolus Therapeutics to Participate in Upcoming Investor Conferences
Feb 17, 2026 09:52 PM Form SCHEDULE 13G/A Autolus Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Feb 17, 2026 06:05 AM H.C. Wainwright Starts Autolus Therapeutics plc (AUTL) at Buy
Feb 16, 2026 10:15 AM CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
Feb 13, 2026 04:09 PM Form SCHEDULE 13G/A Autolus Therapeutics Filed by: MAK Capital Fund LP
Feb 5, 2026 09:26 AM The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
Feb 4, 2026 08:57 AM Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 26, 2026 04:09 PM Form 424B3 Autolus Therapeutics
Jan 26, 2026 04:08 PM Form 8-K Autolus Therapeutics For: Jan 21
Jan 13, 2026 07:13 AM Autolus Therapeutics plc (AUTL) PT Lowered to $8 at Truist Securities
View All Articles

Entities mentioned with AUTL

View All Entities